Real-life Efficacy of Omalizumab After 9 Years of Follow-up

Omalizumab is frequently used as add-on treatment to inhaled corticosteroids (ICS) and long-acting β2-agonists in patients with suboptimal control of severe asthma. Patients with severe asthma will typically require chronic treatment, although due to the limited amount of data available there are st...

Descripción completa

Detalles Bibliográficos
Autores principales: Menzella, Francesco, Galeone, Carla, Formisano, Debora, Castagnetti, Claudia, Ruggiero, Patrizia, Simonazzi, Anna, Zucchi, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2017
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446952/
https://www.ncbi.nlm.nih.gov/pubmed/28497924
http://dx.doi.org/10.4168/aair.2017.9.4.368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446952/
https://www.ncbi.nlm.nih.gov/pubmed/28497924
http://dx.doi.org/10.4168/aair.2017.9.4.368

Ejemplares similares